Related Experiment Video
Updated: May 19, 2026

06:44
Creation of Abdominal Adhesions in Mice
Published on: August 27, 2016
Zn2+-SCMC versus HA for preventing intraperitoneal adhesions: a rat model study
Xiaohong Du1, Guanghui Hong, Pinghui Sun
1Department of Hepatobiliary Surgery, the Norman Bethune First Hospital of Jilin University, Jilin, China.
International Journal of Medical Sciences
|August 29, 2012
Summary
Zinc-modified sodium carboxymethyl cellulose (Zn(2+)-SCMC) significantly reduced postoperative intraperitoneal adhesions compared to hyaluronic acid in a rat model. Zn(2+)-SCMC demonstrated superior efficacy in preventing these adhesions.
Area of Science:
- Surgical Complications
- Biomaterials Science
- Regenerative Medicine
Background:
- Intraperitoneal adhesions are a significant postoperative complication following abdominal surgery.
- Effective prevention strategies are crucial to reduce patient morbidity.
Purpose of the Study:
- To compare the efficacy of zinc-modified sodium carboxymethyl cellulose (Zn(2+)-SCMC) and hyaluronic acid (HA) in preventing postoperative intraperitoneal adhesions.
- To evaluate the potential of Zn(2+)-SCMC as an anti-adhesion agent.
Main Methods:
- A rat model was used to induce peritoneal adhesions by cecal mucosa abrasion.
- Rats were randomized into three groups: no treatment, HA treatment, or Zn(2+)-SCMC treatment.
- Adhesion incidence and severity were assessed two weeks post-treatment via scoring and histological examination.
Main Results:
- The Zn(2+)-SCMC group showed a significantly lower incidence of intraperitoneal adhesions (48.7%) compared to the HA group (77.5%) and the untreated group (77.5%).
- Mortality rates were lowest in the Zn(2+)-SCMC group (2.5%) compared to HA (5.0%) and untreated (12.5%) groups.
- Both agents promoted abdominal serosa repair, but Zn(2+)-SCMC was more effective.
Conclusions:
- Zinc-modified sodium carboxymethyl cellulose (Zn(2+)-SCMC) is more effective than hyaluronic acid in preventing postoperative intraperitoneal adhesions.
- Zn(2+)-SCMC represents a promising therapeutic agent for reducing surgical adhesion formation.
